Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity

Saved in:
Bibliographic Details
Published in:Journal of Clinical Investigation 2022, Vol.132 (24)
Main Authors: Natrup, Christian Meyer zu, Tscherne, Alina, Dahlke, Christine, Ciurkiewicz, Malgorzata, Shin, Dai-Lun, Fathi, Anahita, Rohde, Cornelius, Kalodimou, Georgia, Halwe, Sandro, Limpinse, Leonard, Schwarz, Jan H, Klug, Martha, Esen, Meral, Schneiderhan-Marra, Nicole, Dulovic, Alex, Kupke, Alexandra, Brosinski, Katrin, Clever, Sabrina, Schunemann, Lisa-Marie, Beythien, Georg, Armando, Federico, Mayer, Leonie, Weskamm, Marie L, Jany, Sylvia, Freudenstein, Astrid, Tuchel, Tamara, Baumgartner, Wolfgang, Kremsner, Peter, Fendel, Rolf, Addo, Marylyn M, Becker, Stephan, Sutter, Gerd, Volz, Asisa
Format: Report
Language:English
Subjects:
Genetic aspects
Health aspects
Immune response
Recombinant molecules
Viral antigens
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9738
DOI:10.1172/JCI159895